Showing results (401-410 of 517) with videos related to

Sort By:
Pageof 52
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 6, 2023
Modified integrated tumor burden, liver function, systemic inflammation, and tumor biology score to predict long-term outcomes after resection for hepatocellular carcinomaYutaka Endo, Zorays Moazzam, Laura Alaimo, et al.
Annals of Surgical Oncology|December 1, 2020
Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?Diamantis I Tsilimigras, J Madison Hyer, Anghela Z Paredes, et al.
Annals of Surgical Oncology|May 11, 2020
Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary CentersDiamantis I Tsilimigras, Kota Sahara, Dimitrios Moris, et al.
Annals of Surgical Oncology|June 30, 2010
Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysisSkye C Mayo, Mechteld C de Jong, Carlo Pulitano, et al.
Annals of Surgical Oncology|June 14, 2026
Tumor Burden Modifies the Prognostic Impact of Adequate Lymph Node Dissection in Patients Undergoing Curative-Intent Resection for Intrahepatic CholangiocarcinomaJun Kawashima, Kota Sahara, Kizuki Yuza, et al.
Oncology|February 24, 2021
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma PatientsAndrea Casadei-Gardini, Roberto Filippi, Margherita Rimini, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 18, 2025
Ethics and trustworthiness of artificial intelligence in Hepato-Pancreato-Biliary surgery: a snapshot of insights from the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) surveyNiki Rashidian, Mohammed Abu Hilal, Isabella Frigerio, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2022
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clustersMargherita Rimini, Eleonora Loi, Carles Fabregat-Franco, et al.
Seminars in Oncology|June 10, 2025
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world populationFrancesco Vitiello, Toshifumi Tada, Goki Suda, et al.
Annals of Surgical Oncology|July 9, 2025
Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic CholangiocarcinomaJun Kawashima, Miho Akabane, Mujtaba Khalil, et al.
Pageof 52